• Finalist – Maryland ICON Award (Life Sciences Emerging Company) Spring 2026
• Fzata selected to join Maryland delegation at BIO International 2026 (San Diego)
• Advancing toward first-in-human clinical trials (pending FDA clearance summer 2026)
• Preparing for Series A financing

Bioengineered Probiotic Yeast Medicine (BioPYM): a first-in-class platform for oral live biotherapeutics.
www.nature.com/biopharmdeal 5 July 2023

Link to Article

Fzata, Inc. 1450 S. Rolling Rd, Room 4.097, Halethorpe, Maryland 21227 USA

443.543.5040 info (type @) fzata.com

Bioengineered Probiotic Yeast Medicine (BioPYM): a first-in-class platform for oral live biotherapeutics. www.nature.com/biopharmdeal 5 July 2023

Bioengineered Probiotic Yeast Medicine (BioPYM): a first-in-class platform for oral live biotherapeutics.
www.nature.com/biopharmdeal 5 July 2023